Author:
Fan Dongmei,Liu Pingxian,Jiang Yunhan,He Xinlian,Zhang Lidan,Wang Lijiao,Yang Tao
Abstract
A novel class of quinoxaline–arylfuran derivatives were designed, synthesized, and preliminarily evaluated for their antiproliferative activities in vitro against several cancer cell lines and normal cells. The representative derivative QW12 exerts a potent antiproliferative effect against HeLa cells (IC50 value of 10.58 μM), through inducing apoptosis and triggering ROS generation and the accumulation of HeLa cells in vitro. Western blot analysis showed that QW12 inhibits STAT3 phosphorylation (Y705) in a dose-dependent manner. The BLI experiment directly demonstrated that QW12 binds to the STAT3 recombination protein with a KD value of 67.3 μM. Furthermore, molecular docking investigation showed that QW12 specifically occupies the pY+1 and pY-X subpocket of the SH2 domain, thus blocking the whole transmission signaling process. In general, these findings indicated that the study of new quinoxaline–aryfuran derivatives as inhibitors of STAT3 may lead to new therapeutic medical applications for cancer in the future.
Funder
National Natural Science Foundation of China
West China Hospital, Sichuan University
Reference36 articles.
1. Wild, C.P., Weiderpass, E., and Stewart, B.W. World Cancer Report: Cancer Research for Cancer Prevention, 2020.
2. Review of precision cancer medicine: Evolution of the treatment paradigm;Nikanjam;Cancer Treat. Rev.,2020
3. Quinoxaline derivatives as a promising scaffold for breast cancer treatment;Eldin;New J. Chem.,2022
4. Synthesis and Molecular Docking Study of Novel Hybrids of 1,3,4-Oxadiazoles and Quinoxaline as a Potential Analgesic and Anti-Inflammatory Agents;Dewangan;J. Heterocycl. Chem.,2018
5. Synthesis, Spectroscopy Properties and Antifungal Activity of New Quinoxaline Derivatives;Zhu;Indian J. Heterocycl. Chem.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献